SCHEMBL21803095

SCHEMBL21803095

COc1cn(C)nc1[C@H](N[S+]([O-])C(C)(C)C)C1(C)CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21803099 1.00
SCHEMBL21803097 1.00
SCHEMBL30631995 1.00
SCHEMBL21803125 0.88
SCHEMBL21803124 0.88
SCHEMBL21803123 0.88
SCHEMBL21803133 0.84 CCR7 (0.38)
SCHEMBL21803136 0.84 CCR7 (0.38)
SCHEMBL21803134 0.84 CCR7 (0.38)
SCHEMBL30631973 0.84 CCR7 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12312344-B2 N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors PFIZER INC. (US) 2025-05-27 US disclosed
US-20240368144-A1 N-SUBSTITUTED-DIOXOCYCLOBUTENYLAMINO-3-HYDROXY-PICOLINAMIDES USEFUL AS CCR6 INHIBITORS PFIZER INC. (US) 2024-11-07 US disclosed
CN-116874466-A N-substituted dioxocyclobutylamino-3-hydroxy-pyridinecarboxamides as CCR6 inhibitors 辉瑞公司 2023-10-13 CN disclosed
CN-112672791-B N-substituted dioxocyclobutylamino-3-hydroxy-pyridinecarboxamides as CCR6 inhibitors 辉瑞公司 2023-10-03 CN disclosed
US-11708360-B2 N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors PFIZER INC. (US) 2023-07-25 US disclosed
US-20210206757-A1 N-SUBSTITUTED-DIOXOCYCLOBUTENYLAMINO-3-HYDROXY-PICOLINAMIDES USEFUL AS CCR6 INHIBITORS PFIZER INC. (US) 2021-07-08 US disclosed
CN-112672791-A N-substituted dioxocyclobutenylamino-3-hydroxy-pyridinecarboxamides useful as CCR6 inhibitors 辉瑞公司 2021-04-16 CN disclosed
US-10975065-B2 N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors PFIZER INC. (US) 2021-04-13 US disclosed
US-20200095239-A1 N-SUBSTITUTED-DIOXOCYCLOBUTENYLAMINO-3-HYDROXY-PICOLINAMIDES USEFUL AS CCR6 INHIBITORS PFIZER INC. (US) 2020-03-26 US disclosed